Caseware UK (AP4) 2024.0.164 2024.0.164 2024-09-302024-09-30No description of principal activity22023-10-01false2truetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 08183415 2023-10-01 2024-09-30 08183415 2022-10-01 2023-09-30 08183415 2024-09-30 08183415 2023-09-30 08183415 c:Director1 2023-10-01 2024-09-30 08183415 c:Director2 2023-10-01 2024-09-30 08183415 c:RegisteredOffice 2023-10-01 2024-09-30 08183415 d:OfficeEquipment 2023-10-01 2024-09-30 08183415 d:OfficeEquipment 2024-09-30 08183415 d:OfficeEquipment 2023-09-30 08183415 d:CurrentFinancialInstruments 2024-09-30 08183415 d:CurrentFinancialInstruments 2023-09-30 08183415 d:CurrentFinancialInstruments d:WithinOneYear 2024-09-30 08183415 d:CurrentFinancialInstruments d:WithinOneYear 2023-09-30 08183415 d:ShareCapital 2024-09-30 08183415 d:ShareCapital 2023-09-30 08183415 d:RetainedEarningsAccumulatedLosses 2024-09-30 08183415 d:RetainedEarningsAccumulatedLosses 2023-09-30 08183415 c:OrdinaryShareClass1 2023-10-01 2024-09-30 08183415 c:OrdinaryShareClass1 2024-09-30 08183415 c:OrdinaryShareClass2 2023-10-01 2024-09-30 08183415 c:OrdinaryShareClass2 2024-09-30 08183415 c:OrdinaryShareClass3 2023-10-01 2024-09-30 08183415 c:OrdinaryShareClass3 2024-09-30 08183415 c:OrdinaryShareClass4 2023-10-01 2024-09-30 08183415 c:OrdinaryShareClass4 2024-09-30 08183415 c:OrdinaryShareClass5 2023-10-01 2024-09-30 08183415 c:OrdinaryShareClass5 2024-09-30 08183415 c:FRS102 2023-10-01 2024-09-30 08183415 c:AuditExemptWithAccountantsReport 2023-10-01 2024-09-30 08183415 c:FullAccounts 2023-10-01 2024-09-30 08183415 c:PrivateLimitedCompanyLtd 2023-10-01 2024-09-30 08183415 d:KeyManagementPersonnelCloseFamilyMembersEntitiesUnderKeyManagementPersonnelsControl 2023-10-01 2024-09-30 08183415 2 2023-10-01 2024-09-30 08183415 e:PoundSterling 2023-10-01 2024-09-30 xbrli:shares iso4217:GBP xbrli:pure

Registered number: 08183415









PJS ORTHOPAEDICS LTD







UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 30 SEPTEMBER 2024

 
PJS ORTHOPAEDICS LTD
 
 
COMPANY INFORMATION


Directors
P J Hopgood 
Mrs S Hopgood 




Registered number
08183415



Registered office
7 The Close

Norwich

Norfolk

NR1 4DJ




Accountants
MA Partners LLP
Chartered Accountants

7 The Close

Norwich

Norfolk

NR1 4DJ





 
PJS ORTHOPAEDICS LTD
 

CONTENTS



Page
Accountants' report
 
 
1
Balance sheet
 
 
2 - 3
Notes to the financial statements
 
 
4 - 7


 
PJS ORTHOPAEDICS LTD
 
 
  
CHARTERED ACCOUNTANTS' REPORT TO THE BOARD OF DIRECTORS ON THE PREPARATION OF THE UNAUDITED STATUTORY FINANCIAL STATEMENTS OF PJS ORTHOPAEDICS LTD
FOR THE YEAR ENDED 30 SEPTEMBER 2024

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of PJS Orthopaedics Ltd for the year ended 30 September 2024 which comprise  the Balance sheet and the related notes from the Company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW)we are subject to its ethical and other professional requirements which are detailed at https://www.icaew.com /regulation.

This report is made solely to the Board of directors of PJS Orthopaedics Ltd, as a body, in accordance with the terms of our engagement letter dated 1 September 2022Our work has been undertaken solely to prepare for your approval the financial statements of PJS Orthopaedics Ltd and state those matters that we have agreed to state to the Board of directors of PJS Orthopaedics Ltd, as a body, in this report in accordance with ICAEW Technical Release TECH07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than PJS Orthopaedics Ltd and its Board of directors, as a body, for our work or for this report. 

It is your duty to ensure that PJS Orthopaedics Ltd has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of PJS Orthopaedics Ltd. You consider that PJS Orthopaedics Ltd is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or review of the financial statements of PJS Orthopaedics Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

  





MA Partners LLP
 
Chartered Accountants
  
7 The Close
Norwich
Norfolk
NR1 4DJ

28 March 2025
Page 1

 
PJS ORTHOPAEDICS LTD
REGISTERED NUMBER: 08183415

BALANCE SHEET
AS AT 30 SEPTEMBER 2024

2024
2023
Note
£
£

  

 
Current assets
  

Debtors: amounts falling due within one year
 5 
661,219
565,453

Cash at bank and in hand
  
119,916
47,209

  
781,135
612,662

Creditors: amounts falling due within one year
 6 
(99,061)
(116,847)

Net current assets
  
 
 
682,074
 
 
495,815

Total assets less current liabilities
  
682,074
495,815

  

Net assets
  
682,074
495,815


Capital and reserves
  

Called up share capital 
 7 
225
225

Profit and loss account
  
681,849
495,590

  
682,074
495,815


Page 2

 
PJS ORTHOPAEDICS LTD
REGISTERED NUMBER: 08183415
    
BALANCE SHEET (CONTINUED)
AS AT 30 SEPTEMBER 2024

The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the profit and loss account in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 28 March 2025.






P J Hopgood
Director


The notes on pages 4 to 7 form part of these financial statements.

Page 3

 
PJS ORTHOPAEDICS LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024

1.


General information

The Company is a private company limited by shares.  It is both incorporated and domiciled in England and Wales.  The address of its registered office is 7 The Close, Norwich, Norfolk, NR1 4DJ.
The Company's principal activity is that of the provision of orthopaedic services and the Company's principal place of business is Norwich, Norfolk.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Turnover

Turnover comprises revenue recognised by the Company in respect of the orthopaedic services provided during the year exclusive of Value Added Tax.

 
2.3

Interest income

Interest income is recognised in profit or loss using the effective interest method.

 
2.4

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

 
2.5

Pensions

Defined contribution pension plan

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Balance sheet. The assets of the plan are held separately from the Company in independently administered funds.

Page 4

 
PJS ORTHOPAEDICS LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024

2.Accounting policies (continued)

 
2.6

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.

 
2.7

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Office equipment
-
33% straight line

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.8

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.9

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.10

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

Page 5

 
PJS ORTHOPAEDICS LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024

2.Accounting policies (continued)

 
2.11

Financial instruments

The Company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors.
Debt instruments that are payable or receivable within one year, typically trade debtors and creditors, are measured at the undiscounted amount of the cash or other consideration expected to be paid or received.

 
2.12

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.


3.


Employees

The average monthly number of employees, including directors, during the year was 2 (2023 - 2).


4.


Tangible fixed assets





Office equipment

£



Cost or valuation


At 1 October 2023
11,288



At 30 September 2024

11,288



Depreciation


At 1 October 2023
11,288



At 30 September 2024

11,288



Net book value



At 30 September 2024
-



At 30 September 2023
-

Page 6

 
PJS ORTHOPAEDICS LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024

5.


Debtors

2024
2023
£
£


Trade debtors
35,177
27,773

Amounts owed by joint ventures and associated undertakings
625,000
535,000

Other debtors
1,042
2,680

661,219
565,453



6.


Creditors: Amounts falling due within one year

2024
2023
£
£

Other taxation and social security
1,482
-

Other creditors
93,764
113,217

Accruals and deferred income
3,815
3,630

99,061
116,847



7.


Share capital

2024
2023
£
£
Authorised, allotted, called up and fully paid



75 A Ordinary shares of £1.00 each
75
75
75 B Ordinary shares of £1.00 each
75
75
25 C Ordinary shares of £1.00 each
25
25
25 D Ordinary shares of £1.00 each
25
25
25 E Ordinary shares of £1.00 each
25
25

225

225



8.


Transactions with directors

As at 1 October 2023, the directors owed the Company £2,680.  During the year the Company paid net expenses of £1,638 on behalf of the directors.  As at 30 September 2024, the directors owed the Company £1,042.

 
Page 7